Open Randomized Control Clinical Trial of Pippalyadi vati in Vataja Pratishyaya with special reference to Acute Rhinitis (COMMON COLD)
Overview
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Dr Poonam Laxman Powar
- Enrollment
- 84
- Locations
- 1
- Primary Endpoint
- Pippalyadi Vati is More Effective Than Fexofenadine in Acute Rhinitis (Common Cold )
Overview
Brief Summary
Based on the physician diagnosis incidence of Acute Rhinitis in India ranges
between20% to 30%. 17 Studies have shown that prevalence of Acute
rhinitis has been increasing in India over past few years. Thus the study will
be carried out to find out the solution for the relief from Acute Rhinitis
(VatajaPratishyaya).
The disease VatajaPratishyaya which is due to vitiation of vatadosha in
nasa region is comparable with Acute Rhinitis which is more common now
a day due to increased pollution and changes in lifestyle.VatajaPratishyaya
has symptoms like Aanaddhapihita, Tanustrava, Kshawathu,which are also
present in Acute Rhinitis(common cold) as a nasal blockage, rhinorrhoea,
sneezing.
Treatment for the Acute Rhinitis(common cold) is antihistamines and
steroids etc and their side effects are drowsiness,dizziness and headache.
Ayurveda has much effective treatment modalities for VatajaPratishyaya.
Hence the present study will be carried out to evaluate the efficacy of
PippalyadiVatiinVatajaPratishyaya.
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients suffering from theVatajaPratishyaya (Acute Rhinitis-common cold).
- •Patients of Age Group 18 To 60 years, irrespective of their gender, religion, occupation.
- •All patients having signs and symptoms.
- •1.Aanaddhapihita (Nasal Obstruction) 2.Tanustrava (Rhinorrhoea)
- •Kshavathu (Sneezing)
- •jwara (fever).
Exclusion Criteria
- •Pregnant women and children
- •History of congenital disorder of nose
- •Known cases of chronic specific infective rhinitis, syphilis, leprosy, tuberculosis, Lupus vulgaris, fungal infections,
- •Patients with nasal polyp, neoplasm.
Outcomes
Primary Outcomes
Pippalyadi Vati is More Effective Than Fexofenadine in Acute Rhinitis (Common Cold )
Time Frame: 1 BD for 7 days
Secondary Outcomes
- Pippalyadi vati is equally effective as Fexofenadine in Acute Rhinitis (Common Cold).(1 BD for 7 days)
Investigators
Dr Poonam Laxman Powar
Hon Shri Annasaheb Dange Ayurved Medical College and Post Graduate research centre Ashta